https://azd6738inhibitor.com/b....iomechanical-custom-
The malignant cancer hepatocellular carcinoma is among the most lethal in the world. A poor prognosis and the absence of effective treatments, particularly for patients with advanced cancer, underscore the critical need for novel therapies and innovative therapeutic targets. Scrutinizing the U.S. Food and Drug Administration's drug database against hepatocellular carcinoma (HCC) cell lines, we determined that
Me gusta
Comentario
Compartir
